Ketek's new labeling approved by FDA

Share this article:
Ketek (telithromycin), Sanofi-Aventis' antibiotic, has had new labeling approved by the FDA, including a bolded warning and additional information on liver toxicity and failure, as well as revised recommendations for use in patients with myasthenia gravis. The agency says Ketek's benefits outweigh its potential risks when used according to the labeling.
Share this article:

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...